Advertisement

Topics

Evidence Supporting Interpace Diagnostics' PanDNA® Product Presented at the American College of Gastroenterology Annual Meeting

12:08 EDT 19 Oct 2016 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
LAS VEGAS, Oct. 19, 2016 /PRNewswire/ -- Interpace Diagnostics Group (NASDAQ: IDXG), a company that provides specialized molecular diagnostic tests and pathology services, reported today, from the American College of Gastroenterology (ACG) Annua...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Evidence Supporting Interpace Diagnostics' PanDNA® Product Presented at the American College of Gastroenterology Annual Meeting"

Quick Search
Advertisement
 

Relevant Topics

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...

Pancreatic Cancer
The pancreas secretes a number of important hormones into the digestive tract and the blood stream. Cancers are most commonly exocrine than endocrine (neuroendocrine) tumors. Functional tumors secrete hormones; Insulinoma, Gastrinoma, Somatostatinoma, VI...